Foetal and Neonatal Alloimmune Thrombocytopaenia
Author Information
Author(s): Kaplan Cecile
Primary Institution: Institut National de Transfusion Sanguine
Hypothesis
NAIT results from maternal alloimmunisation against foetal platelet antigens inherited from the father.
Conclusion
Prompt diagnosis and treatment of NAIT are essential to reduce the chances of death and disability due to haemorrhage.
Supporting Evidence
- NAIT is the commonest cause of severe isolated thrombocytopaenia in the foetus and newborn.
- Approximately 20% of affected infants show evidence of intracranial haemorrhage.
- Prompt diagnosis and treatment are essential to reduce the chances of death and disability.
Takeaway
Sometimes, babies can have low platelet counts because their mom's body makes antibodies against their platelets. This can cause serious bleeding, so doctors need to act quickly.
Methodology
The diagnosis is confirmed by demonstrating maternal antiplatelet alloantibodies directed against paternal antigens.
Limitations
Management of high-risk pregnancies is still a matter of discussion.
Participant Demographics
Typically, the mother is healthy with no previous history of thrombocytopaenia or autoimmune disorders.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website